ARCHIVES

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

PDQ Now Offers CME Credit to Physician Users

July 3, 1987

The Duke Scandal: NEJM Retracts Potti Paper

March 4, 2011

ACS Medals Of Honor To Bonadonna, Hsu, Louis Sullivan

December 13, 1991

Questions Still Surround 88 BCDDP Patients Found With Minimal Cancer; DCCR Asks for Another Review

October 28, 1977

In Brief: UICC Honors Dodd; Centers Recognize Nealon; Tale Expands Transplant Program

March 28, 1997

“Soft Soap” Comprehensive Center Review Still Stung Some; NSAB Left With Perplexing Situations

May 26, 1978